Cargando…
Polymer-Based Delivery of Glucagon-Like Peptide-1 for the Treatment of Diabetes
The incretin hormones, glucagon-like peptide-1 (GLP-1) and its receptor agonist (exendin-4), are well known for glucose homeostasis, insulinotropic effect, and effects on weight loss and food intake. However, due to the rapid degradation of GLP-1 by dipeptidylpeptidase-IV (DPP-IV) enzyme and renal e...
Autores principales: | Kim, Pyung-Hwan, Kim, Sung Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369441/ https://www.ncbi.nlm.nih.gov/pubmed/22701182 http://dx.doi.org/10.5402/2012/340632 |
Ejemplares similares
-
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017) -
Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011) -
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017) -
Glucagon-Like Peptide-1 and Diabetes 2012
por: Monami, Matteo, et al.
Publicado: (2012) -
Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)